The Non-invasive Fat Reduction Market was valued at USD 1.6 billion in 2023. The Global Non-invasive Fat Reduction market industry is projected to grow from USD 1.8 billion in 2024 to USD 5.6 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.00% during the forecast period (2024 - 2032). The increasing need for body shapers and the growing prevalence of obesity are the primary market drivers propelling the market's expansion.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The process of ultrasonic liposuction, often known as ultrasound fat removal, liquifies fat cells prior to their extraction. An ultrasound is combined with ultrasonic waves to target fat cells. Because ultrasound-assisted liposuction spares surrounding nerves, it is thought to be safer and more accurate. The market's expansion is anticipated to be bolstered throughout the projected period by the growing relevance of ultrasound technology in non-invasive fat removal. For example, targeted ultrasonic cavitation combined with aerobic activity is a more effective way to reduce abdominal and intrahepatic fat (a study published in PLOS One in April 2021). Consequently, the market CAGR is anticipated to grow due to the significance of ultrasound technology in treating disorders like non-alcoholic fatty liver disease by reducing body fat.
A significant factor that might drive the expansion of this sector throughout the projected period is the growing number of people using minimally invasive treatments. Growth in the sector is being driven by major companies in the market introducing many ultrasonic fat removal devices. As an illustration, Alma introduced Alma PrimeX, a non-invasive fat-removal treatment, in April 2021. Utilizing a unique blend of radiofrequency and ultrasonic technologies, Alma's PrimeX treatment targets adipose tissue specifically, decreasing the thickness of fat.
As opposed to single-modality therapies, combining several technologies may be able to target fat cells through a variety of methods, resulting in a more noticeable decrease in fat. While ultrasound may encourage lymphatic drainage to eliminate the broken-down fat, radiofrequency may damage the membranes surrounding fat cells. Everybody has different needs. Certain individuals may require a more invasive therapy due to intractable fat pockets, while others may emphasize skin tightening. Combining technology enables customized treatment programs that target certain issues.
Devices for use at home provide a more accessible and convenient option than operations performed in a clinic. Individuals may indulge in self-care at their own pace and the convenience of their own homes. Consumer interest in at-home beauty products and self-care is rising. Devices for home usage meet this need by providing a means of body-reshaping objectives without requiring significant therapeutic intervention. Thus, this drives the revenue from the non-invasive fat reduction market.
Based on Technology, the Non-invasive Fat Reduction Market segmentation includes cryolopolysis, lower-level lasers, ultra-sound, and others. In 2023, the cryolopolysis segment dominated the market. Individuals are choosing a low-risk operation that yields both short-term and long-term benefits. It is anticipated that demand for cryolipolysis will rise due to its lower cost, lack of downtime, frequent concerns like temporary pain, and numerous campaigns launched by prominent parties to enhance public awareness of the device's advantages and safety.
The lower-level lasers category is anticipated to be the fastest growing. Patients may get back to their regular activities right away following lower-level laser treatments since they usually cause no discomfort and require no recovery time. Repeat treatments are encouraged, and the increased comfort and convenience increase patient satisfaction. Clinical trials and research have demonstrated the usefulness of lower-level laser technology in reducing body fat and enhancing body shape, hence supporting its efficacy in fat reduction.
Figure 1: Non-invasive Fat Reduction Market by Technology, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Based on End-User, the Non-invasive Fat Reduction Market segmentation includes hospitals, standalone practices, multispecialty clinics, and others. In 2023, the hospitals category generated the most income. This is mostly because hospitals are outfitted with the newest technology, fat-loss instruments, skilled medical professionals, and the facilities required to perform such treatments. When the therapy is given in a hospital setting, there is also an element of trust and dependability. The accreditation of a facility is an important feature that impacts patients' preferences for cosmetic operations in a good way.
The Non-invasive Fat Reduction multispecialty clinics segment market is anticipated to grow fastest during the forecast period. These clinics provide a variety of procedures, qualified practitioners, and a single, convenient facility that caters to all of the patient's needs. In the coming years, the industry is expected to expand rapidly and have extremely high demand, which will boost revenue and market size.
The study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World by region. The North American Non-invasive Fat Reduction market will dominate this market. This is explained by the growing number of obese people in the area, increased R&D spending, the greatest per capita disposable income, growing use of new technologies, and ongoing awareness initiatives. The expansion of the regional market is being driven by the growing requirement for physical attributes that convey confidence and a flawless look in the primary domains of work. Convenient procedure development and simple access to healthcare facilities contribute to the nation's progress.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: NON-INVASIVE FAT REDUCTION MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Non-invasive Fat Reduction market accounts for the second-largest market share. Europeans are becoming increasingly interested in aesthetic surgery; non-invasive fat removal is a less intrusive alternative. This increasing demand creates a solid market basis. Further, the German Non-invasive Fat Reduction market held the largest market share, and the UK Non-invasive Fat Reduction market was the fastest-growing market in the European region.
The Asia-Pacific Non-invasive Fat Reduction Market is expected to grow at the fastest CAGR from 2024 to 2032. The availability and advantages of body contouring procedures, growing patient awareness, the accessibility of these procedures, their low cost, the growing desire for beauty, the assimilation of Western culture, and the leading players' marketing tactics are all responsible for this increase. Throughout the forecast period, the Asia Pacific region's market is anticipated to develop as a result of the combination of all these variables. Moreover, China’s Non-invasive Fat Reduction market held the largest market share, and the Indian Non-invasive Fat Reduction market was the fastest-growing market in the Asia-Pacific region.
The industry's leading players will keep spending a lot of money on research and development to increase their product lines, which will propel the Non-invasive Fat Reduction market's growth. Contractual agreements, mergers and acquisitions, increased investments, collaboration with other companies, and the production of new products are examples of significant market developments. To increase their worldwide reach, market players also take part in a variety of strategic initiatives. In order to survive and expand in a more competitive and dynamic market, the Non-invasive Fat Reduction industry must offer reasonably priced products and services.
One of the main strategies manufacturers use in the worldwide Non-invasive Fat Reduction market is local manufacturing, which expands the market sector and helps customers by lowering operating costs. The Non-invasive Fat Reduction industry has recently provided some of the largest medical advantages. Major players in the Non-invasive Fat Reduction market, including Cynosure, Zeltiq Aesthetics, Fosun Pharmaceuticals Co. Ltd, Cutera Inc., Candela Corporation, Venus Concept, BTL Industries, Lynton Lasers Ltd., Hologic, Inc., AbbVie Inc., and others, are making investments in R&D activities in an effort to boost market demand.
Specialty biopharmaceutical business AbbVie Inc. (AbbVie) finds, develops, produces, and markets medications for the management of complicated and long-term illnesses. Its medications are approved for the treatment of rheumatoid arthritis, neurological disorders, skin illnesses, endometriosis-related pain, pediatric Crohn's disease, cancer, and other severe medical problems. Additionally, AbbVie is progressing its pipeline initiatives for the treatment of neurological conditions, autoimmune illnesses, Crohn's disease, Parkinson's disease, and cosmetics. AbbVie announced in February 2024 that the purchase of ImmunoGen had been completed. After the transaction was completed, ImmunoGen became a part of AbbVie.
Privately held BTL Industries develops and produces equipment for physiotherapy, cardiology, and aesthetics. 400 R&D engineers and more than 3800 workers make up BTL, which has direct offices in more than 85 locations on five continents. Pneumology, physical therapy, medical aesthetics, and cardiology, which include stress test systems and heart monitoring, are its main divisions. BTL's medical aesthetic range encompasses cutting-edge systems for cellulite treatment, skin tightening, hair removal, and face treatments, in addition to non-invasive body shaping technologies for body sculpting and fat cell disruption. BTL has a network of independent distributors and direct sales operations spread over more than 70 countries on five continents to carry out its global marketing campaigns. In January 2022, BTL added Austria to its global network. By introducing advancements across several medical disciplines, BTL significantly expanded the scope of its product line. Every product has 350 engineers working behind it, all focused on creating innovative treatments.
March 2023: A customized, convenient, and comprehensive approach to fat reduction and muscle toning with 15-minute treatment options is provided by CUTERA, INC.'s award-winning "truBody" brand, which features clinically proven technologies. The "truSculpt" product line is designed for fat reduction for muscle toning and is a quick and efficient combination approach that enables practitioners and patients to achieve optimal results.
April 2022: The United States dermatological offices now have more patient financing alternatives thanks to an exclusive partnership between CUTERA INC. and Synchrony, a supplier of consumer payment and finance solutions.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 1.6 Billion |
| Market Size 2024 | USD 1.8 Billion |
| Market Size 2032 | USD 5.6 Billion |
| Compound Annual Growth Rate (CAGR) | 17.00% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019-2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Technology, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Cynosure, Zeltiq Aesthetics, Fosun Pharmaceuticals Co. Ltd, Cutera Inc., Candela Corporation, Venus Concept, BTL Industries, Lynton Lasers Ltd., Hologic, Inc., and AbbVie Inc. |
| Key Market Opportunities | · Non-invasive muscle-building integration and partnership with the fitness and wellness industry |
| Key Market Dynamics | · Increasing need for body shapers and the growing prevalence of obesity |
Frequently Asked Questions (FAQ) :
The Non-invasive Fat Reduction Market size was valued at USD 1.6 Billion in 2023.
The global market is projected to grow at a CAGR of 17.00% during the forecast period, 2024-2032.
North America had the largest share of the global market
The key players in the market are Cynosure, Zeltiq Aesthetics, Fosun Pharmaceuticals Co. Ltd, Cutera Inc., Candela Corporation, Venus Concept, BTL Industries, Lynton Lasers Ltd., Hologic, Inc., and AbbVie Inc.
The Cryolopolysis category dominated the market in 2023.
Hospitals are the largest share of the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
